Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: A population-based case-control study

Thorax

Volumn 69, Issue 3, 2014, Pages 207-215

  Navaratnam, Vidya ^a,b   Fogarty, Andrew W ^a   McKeever, Tricia ^a   Thompson, Norma ^b   Jenkins, Gisli ^b   Johnson, Simon R ^a   Dolan, Gerard ^c   Kumaran, Maruti ^c   Pointon, Kate ^c   Hubbard, Richard B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBOTIC STATE; RISK ASSESSMENT; THROMBOSIS; VERY ELDERLY;

IDIOPATHIC PULMONARY FIBROSIS; INTERSTITIAL FIBROSIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTHROMBIN; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84893934829     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203740     Document Type: Article

References (39)

1. Navaratnam V, Fleming KM, West J, et al The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011; 66:462-7.
2. Gribbin J, Hubbard RB, Le Jeune I, et al Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61:980-5. (Pubitemid 44787169)
3. Raghu G, Weycker D, Edelsberg J., et al Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:810-16. (Pubitemid 44511663)
4. Coward WR, Saini G, Jenkins G. The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2010; 4:367-88.
5. Chambers RC. Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling. Eur Respir Rev 2008; 17:130-7.
6. Chambers RC. Role of coagulation cascade proteases in lung repair and fibrosis. Eur Respir J Suppl 2003; 44:33s-5s. (Pubitemid 37222060)
7. Chambers RC, Scotton CJ Coagulation cascade proteinases in lung injury and fibrosis. Proc Am Thorac Soc 2012; 9:96-101.
8. Hubbard RB, Smith C, Le Jeune I, et al The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008; 178:1257-61.
9. Sode BF, Dahl M, Nielsen S.F., et al Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med 2010; 181:1085-92.
10. Sprunger DB, Olson AL, Huie T.J., et al Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J 2012; 39:125-32.
11. Kubo H, Nakayama K, Yanai M., et al Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005; 128:1475-82. (Pubitemid 41324435)
12. Noth I, Anstrom KJ, Calvert S.B., et al A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2012; 186:88-95.
13. Walker ID, Greaves M, Preston FE Investigation and management of heritable thrombophilia. Br J Haematol 2001; 114:512-28. (Pubitemid 32953628)
14. Nicolaides AN, Breddin HK, Carpenter P, et al Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 2005; 24:1-26. (Pubitemid 43933045)
15. Miller MR, Hankinson J, Brusasco V., et al Standardisation of spirometry. Eur Respir J 2005; 26:319-38. (Pubitemid 41079078)
16. Wanger J, Clausen JL, Coates A, et al Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511-22. (Pubitemid 41264217)
17. MacIntyre N, Crapo RO, Viegi G, et al Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26:720-35. (Pubitemid 41448672)
18. Raghu G, Collard HR, Egan J.J., et al An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824.
19. Navaratnam V, Pointon K, Kumaran M., et al Are radiological appearances in pulmonary fibrosis dependent on the experience of the reporting radiologist and can they predict survival? Am J Respir Crit Care Med 2012; 185(1 Meeting Abstracts):A4380.
20. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998; 113:396-400. (Pubitemid 28110017)
21. Mapel DW, Hunt WC, Utton R, et al Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 1998; 53:469-76. (Pubitemid 28308062)
22. King TE Jr., Tooze JA, Schwarz M.I., et al Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164:1171-81. (Pubitemid 33052246)
23. Fell CD, Martinez FJ, Liu L.X., et al Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181:832-7.
24. Flaherty KR, Thwaite EL, Kazerooni E.A., et al Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58:143-8. (Pubitemid 36183002)
25. Raghu G, Mageto YN, Lockhart D, et al The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. Chest 1999; 116:1168-74. (Pubitemid 29535965)
26. Hunninghake GW, Zimmerman MB, Schwartz D.A., et al Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164:193-6. (Pubitemid 34001280)
27. Quadrelli S, Molinari L, Ciallella L., et al Radiological versus histopathological diagnosis of usual interstitial pneumonia in the clinical practice: does it have any survival difference? Respiration 2010; 79:32-7.
28. Leslie KO, Cool CD, Sporn T.A., et al Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Arch Pathol Lab Med 2012; 136:1366-76.
29. Chapman HA, Allen CL, Stone OL Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986; 133:437-43. (Pubitemid 16126278)
30. Kotani I, Sato A, Hayakawa H., et al Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 1995; 77:493-504.
31. Senoo T, Hattori N, Tanimoto T., et al Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. Thorax 2010; 65:334-40.
32. Howell DC, Goldsack NR, Marshall R.P., et al Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 2001; 159:1383-95. (Pubitemid 32947968)
33. Hernandez-Rodriguez N.A., Cambrey AD, Harrison N.K., et al Role of thrombin in pulmonary fibrosis. Lancet 1995; 346:1071-3.
34. Ohba T, McDonald JK, Silver R.M., et al Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol 1994; 10:405-12.
35. Jenkins RG, Su X, Su G., et al Ligation of protease-activated receptor 1 enhances alpha(v) beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006; 116:1606-14.
36. Bogatkevich GS, Gustilo E, Oates J.C., et al Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol 2005; 288:L190-201. (Pubitemid 40023901)
37. Chambers RC, Dabbagh K, McAnulty R.J., et al Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J 1998; 333 (Pt 1):121-7. (Pubitemid 28342501)
38. Yasui H, Gabazza EC, Tamaki S, et al Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001; 163:1660-8. (Pubitemid 32578773)
39. Gunther A, Lubke N, Ermert M., et al Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 2003; 168:1358-65. (Pubitemid 37487332)